Tumor necrosis factor alpha antagonists (anti-TNFαs) have been widely used to treat autoimmune conditions including psoriasis, psoriatic arthritis, ankylosing spondyloarthropathies, rheumatoid arthritis, and inflammatory bowel disease. Here, TNF is linked to psoriatic arthritis.